Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET AAA
NCT07473102Phase 1Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 64Cu-RYM2 in abdominal aortic aneurysm (AAA), sponsored by Washington University School of Medicine. Primary endpoint: Standard Uptake Value at 2 years. Started Nov 2025; status: recruiting.
02
Drugs
64Cu-RYM2
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT07473102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07473102.